Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 222 (RN7SKP222) is a "pseudogene" related to the functional non-coding RNA gene RN7SK, which encodes 7SK small nuclear RNA. Pseudogenes are genomic elements that share sequence similarity with functional genes but are generally non-functional, lacking the capacity to produce active RNA or protein. RN7SKP222 does not encode a functional RNA and is not characterized as a therapeutic target, receptor, enzyme, transporter, or other druggable entity. The functional 7SK RNA itself is involved in the regulation of transcription elongation via the P-TEFb snRNP complex[1][4]. There is no evidence that RN7SKP222 plays an active role in biological processes, disease, or drug response[3][5][6]. This name appears correctly formed for a pseudogene but is not a valid drug discovery or pharmacological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 222 (RN7SKP222).